Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
qsC9kaRAAK8gzYbv
Listen
